Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Onset and treatment of infantile leukaemia

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 17.06.18
Views: 630

Dr Anindita Roy - University of Oxford, Oxford, UK

Dr Roy speaks with ecancer at EHA 23 about the inciting mutations that drive infantile leukaemia.

She identifies a unique foetal progenitor cell linked to the disease aetiology, and how a single mutation can start the sequence of changes leading to leukaemia.

Dr Roy also spoke with ecancer about mapping the changes in blood stem cells over a patients life, here.

Related videos

follow us

Call for Papers

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation